A cavernous malformation is a cluster of abnormal blood vessels, usually in the brain or spinal cord, where tightly packed thin-walled vessels form a small, mulberry-shaped mass. The vessels contain slow-moving blood that is often clotted. These formations can range from completely harmless, discovered by accident on a brain scan, to the source of seizures, bleeding, or neurological problems depending on their size and location.
How Cavernous Malformations Form
Normal blood vessels have strong walls reinforced by proteins that keep cells tightly connected. In a cavernous malformation (also called a cavernoma or CCM), those connections are weakened. The result is a bundle of fragile, irregularly shaped vessels prone to slow leaking. Unlike other vascular problems in the brain, cavernomas don’t involve high-pressure arterial blood flow. The blood inside them moves sluggishly and tends to clot in place, which is why many never cause problems at all.
On MRI, they have a distinctive look: a mixed-signal core surrounded by a dark rim of old blood products, reflecting repeated tiny leaks over time. Somewhere between 6% and 65% of people with cavernomas are completely asymptomatic, their lesions found incidentally when an MRI is done for an unrelated reason.
Sporadic vs. Familial Forms
Most cavernous malformations are sporadic, meaning they appear on their own without a clear genetic cause. A person with the sporadic form typically has a single lesion.
The familial form is different. It runs in families and is caused by mutations in one of three genes: KRIT1, CCM2, or PDCD10. These genes produce proteins that work together at the junctions between blood vessel cells, essentially acting as the glue that keeps vessel walls sealed. A mutation in any one of them weakens that seal, allowing vessels to become leaky and malformed. Mutations in these three genes account for 85% to 95% of all familial cases. People with the familial form often develop multiple cavernomas rather than just one, and newer imaging techniques can reveal lesions that older scans miss entirely.
Common Symptoms
When cavernous malformations do cause symptoms, the most common by far are seizures, accounting for roughly 40% to 50% of symptomatic cases. Bleeding into surrounding brain tissue accounts for about 25% of presentations, and focal neurological deficits (weakness, numbness, vision changes, or coordination problems) make up another 25%.
Where the lesion sits in the brain determines what symptoms look like. Cavernomas in the upper parts of the brain most often trigger seizures, while those in the brainstem or lower brain regions tend to cause coordination problems or specific neurological deficits instead. Headaches are common in people with cavernomas, though it can be difficult to confirm the cavernoma itself is the cause rather than something coincidental like tension headaches or migraines.
Incidental cavernomas that have never bled carry a very low risk of causing epilepsy, around 1% to 2%.
Why Location Matters
A cavernoma sitting in a relatively “quiet” part of the brain may never cause noticeable problems, even if it leaks slightly. Brainstem cavernomas are a different story. The brainstem is packed with vital nerve pathways in a very small space, making it highly sensitive to even minor bleeding. The pons, a section in the middle of the brainstem, is the most common location for brainstem lesions, accounting for about 63% of them.
Research on untreated brainstem cavernomas has identified two features that predict worse outcomes. Lesions that cross the midline of the brainstem, affecting structures on both sides, carry roughly 2.3 times the risk of worsening neurological function compared to those that stay on one side. The presence of an associated developmental venous anomaly, a separate type of vein abnormality, also raises that risk. Patients with both features had a 26% rate of worsened outcomes, compared to just 5.3% in patients with neither.
How Cavernomas Are Diagnosed
MRI is the best tool for detecting cavernous malformations. Standard T2-weighted sequences show the characteristic mixed-signal core with a dark border, but specialized sequences pick up far more. Gradient-echo (GRE) imaging has long been considered the gold standard because it is especially sensitive to blood products. A newer technique called susceptibility-weighted imaging (SWI) is even more sensitive, detecting significantly more lesions than both standard and GRE sequences. This is particularly important for people with the familial form, where accurately counting all lesions helps guide management.
CT scans and angiograms are much less useful. Cavernomas often don’t show up on angiography at all because the blood flow through them is so slow, which historically earned them the name “angiographically occult” malformations.
Treatment: Observation vs. Surgery
For asymptomatic cavernomas, observation is the standard approach. The natural course of incidental lesions is generally benign enough that preventive surgery is not warranted. Monitoring with periodic MRI is typical.
Surgery becomes a consideration when a cavernoma causes repeated bleeding, difficult-to-control seizures, or progressive neurological symptoms. Microsurgical removal is the preferred treatment when the lesion is accessible. It has a 97% efficacy rate, compared to 86% for focused radiation (radiosurgery), with similar overall risk profiles. Focused radiation is reserved for cavernomas in locations where open surgery would carry unacceptable risk, such as deep brainstem lesions that have already bled.
For seizures specifically, surgical removal after even a first seizure offers an 88% chance of long-term seizure freedom, compared to 32% with medication alone. That doesn’t mean everyone with a seizure needs surgery right away, but it is a strong option for people who want to come off anti-seizure medications or who don’t tolerate them well.
Brainstem cavernomas follow a more cautious strategy. A common approach is to manage conservatively after a first bleed and consider surgery only after a second, since the surgical risks in the brainstem are higher and a single bleed may not recur.
Living With a Cavernous Malformation
Many people learn they have a cavernoma and never need treatment. The diagnosis can feel alarming, especially when the words “brain” and “malformation” appear together, but the reality for most is periodic imaging and an otherwise normal life. Incidental lesions that have never bled and never caused seizures have a very low chance of suddenly becoming problematic.
For those with symptomatic cavernomas, the path depends on how the lesion behaves over time. A single seizure or small bleed doesn’t automatically mean surgery. Doctors weigh the location, the pattern of symptoms, whether bleeding has happened more than once, and how much the symptoms affect daily life. Because cavernomas are not cancerous and don’t grow aggressively, there is usually time to make careful, informed decisions rather than rushing into intervention.